Cedars-Sinai Cancer Gut Microbiome Finding: Optimal Mix of Bacteria & Fungi May Improve Radiation Therapy for Cancer Patients

In a fascinating breakthrough, Los Angeles-based cancer researchers recently discovered that intestinal microorganisms actually regulate anti-tumor immune responses to radiation treatments—additionally, fungi and bacteria appear to oppose those particular responses. Cedars-Sinai Cancer preclinical research conducted on mice reveals a path toward improving the effectiveness of radiation and immune-based treatments for patients with melanoma, breast, and other cancers. The principal investigator now seeks to characterize the diversity of gut microorganisms in cancer patients undergoing treatment on a mission to better understand the mechanisms by which gut microbiota, such as bacteria and fungi, influence cancer therapies. A patent has been secured for an antifungal agent as well.

With their results published recently in the peer-reviewed journal Cancer Cell, this particular research was undertaken in a vacuum but rather follows previous studies involving the role of intestinal bacteria in influencing immune responses to chemotherapy and immunotherapy. In this investigation, Cedars-Sinai researchers led by Dr. Stephen L. Shiao investigated the role of both gut-related bacteria an...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee